NASDAQ:ELEV
Elevation Oncology, Inc.
- Stock
Last Close
3.61
17/05 20:00
Market Cap
117.06M
Beta: -
Volume Today
173.09K
Avg: 819.79K
PE Ratio
−2.16
PFCF: −1.98
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
net income | -5.88M - | -17.27M 193.52% | -32.04M 85.57% | -95.08M 196.76% | -45.70M 51.93% | |
depreciation and amortization | 15K - | 18K 20% | 27K 50% | 39K 44.44% | ||
deferred income tax | 5.14M - | -1.64M 131.87% | 5.86M - | |||
stock based compensation | 13.50 - | 52K 385,085.19% | 1.57M 2,921.15% | 3.21M 104.07% | 3.33M 4.02% | |
change in working capital | 423K - | 4.90M 1,058.39% | 283K 94.22% | 6.29M 2,122.61% | -13.69M 317.65% | |
accounts receivables | ||||||
inventory | ||||||
accounts payables | 460K - | 5.22M 1,034.57% | -30K 100.57% | 711K 2,470% | -5.86M 923.49% | |
other working capital | -37K - | -319K 762.16% | 313K 198.12% | 5.58M 1,682.43% | -7.83M 240.44% | |
other non cash items | 8.99K - | -5.14M 57,263.52% | 1.64M 131.87% | 74K 95.48% | -6.01M 8,228.38% | |
net cash provided by operating activities | -5.45M - | -12.30M 125.65% | -30.17M 145.30% | -85.48M 183.37% | -56.18M 34.28% | |
investments in property plant and equipment | -71K - | -86K - | ||||
acquisitions net | 44.31K - | |||||
purchases of investments | -112.31M - | -42.66M 62.02% | ||||
sales maturities of investments | 68M - | 54.20M 20.29% | ||||
other investing activites | -44.31K - | |||||
net cash used for investing activites | -71K - | -44.40M - | 11.54M 126.00% | |||
debt repayment | -470K - | |||||
common stock issued | 7.19M - | 20K 99.72% | 97.06M 485,210.00% | 19K 99.98% | 48.00M 252,526.32% | |
common stock repurchased | -35K - | -24K 31.43% | ||||
dividends paid | ||||||
other financing activites | 10.79K - | 90.01M 834,475.80% | -11K 100.01% | 30M 272,827.27% | ||
net cash used provided by financing activities | 7.19M - | 90.03M 1,152.14% | 97.05M 7.80% | 29.51M 69.59% | 47.98M 62.55% | |
effect of forex changes on cash | ||||||
net change in cash | 1.74M - | 77.66M 4,363.22% | 66.88M 13.88% | -100.37M 250.06% | 3.34M 103.33% | |
cash at beginning of period | 1.74M - | 79.40M 4,463.22% | 146.28M 84.24% | 45.92M 68.61% | ||
cash at end of period | 1.74M - | 79.40M 4,463.22% | 146.28M 84.24% | 45.92M 68.61% | 49.26M 7.27% | |
operating cash flow | -5.45M - | -12.30M 125.65% | -30.17M 145.30% | -85.48M 183.37% | -56.18M 34.28% | |
capital expenditure | -71K - | -86K - | ||||
free cash flow | -5.45M - | -12.37M 126.95% | -30.17M 143.89% | -85.57M 183.65% | -56.18M 34.35% |
All numbers in USD (except ratios and percentages)